Health
Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases – News-Medical.Net
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β…
Reviewed by Emily Henderson, B.Sc.Nov 25 2020
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.
The catalyst was able to oxygenate Aβ embedded under the skin of a living mouse, and diminished intact Aβ level in AD-model mouse brain. The new catalyst is potentially applicable for the treatment of peripheral amyloid…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News16 hours agoWest End icon closes doors
-
General18 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay